Monash University’s Precision Medicine research group has discovered multiple new genetic risk factors that make men susceptible to aggressive prostate cancer that will contribute to future prevention of the disease.
Reported in a series of articles published in the prestigious international journals European Urology, Journal of the National Cancer Institute and International Journal of Cancer, the combined research outcomes of these studies validate that genetic alterations in the BRCA2, PALB2 and ATM genes are associated with prostate cancer risk in men that have a strong family history and elevates their risk of an aggressive form of the disease.